| Bolaji Olatoun Bolarinwa, | |
|
750 Route 73 S Ste 105a, Marlton, NJ 08053-4142 | |
| (856) 282-5566 | |
| Not Available |
| Full Name | Bolaji Olatoun Bolarinwa |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 5 Years |
| Location | 750 Route 73 S Ste 105a, Marlton, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104476381 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LP0808X | Nurse Practitioner - Psychiatric/mental Health | 26NJ00955200 (New Jersey) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St Remi Llc | 0042456683 | 3 |
News Archive
Gen-Probe Incorporated announced today that the Company has begun a clinical trial intended to secure U.S. regulatory approval of its PROGENSA(R) PCA3 assay, a new molecular test that may help determine the need for a repeat prostate biopsy.
Moffitt Cancer Center researchers developed a new way to identify possible therapeutic targets for patients with drug resistant melanoma. It involves using liquid chromatography-multiple reaction monitoring mass spectrometry to measure biomarkers or molecules in blood and tissue that indicates cancer is present. These measurements can help researchers determine if a patient is responding to treatment.
The Associated Press looks at some anticipated changes to the "National Security Strategy, a document that previously outlined the Bush Doctrine of preventive war." The article focuses on the prospective strategy changes, but notes that the "revisions are part of a larger effort about which the White House talks openly, one that seeks to change not just how the U.S. talks to Muslim nations, but also what it talks to them about, from health care and science to business startups and education."
OrSense Ltd., developer of monitors for non-invasive measurements of various blood parameters, presented today at the AABB Annual Meeting & CTTXPO 2010, in Baltimore, Maryland, results showing that hemoglobin (Hb) measurements obtained by its NBM 200, a non-invasive Hb measurement system for anemia screening, showed accurate performance compared with invasive point of care (POC) devices.
› Verified 4 days ago
| Entity Name | St Remi Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144583519 PECOS PAC ID: 0042456683 Enrollment ID: O20130426000191 |
News Archive
Gen-Probe Incorporated announced today that the Company has begun a clinical trial intended to secure U.S. regulatory approval of its PROGENSA(R) PCA3 assay, a new molecular test that may help determine the need for a repeat prostate biopsy.
Moffitt Cancer Center researchers developed a new way to identify possible therapeutic targets for patients with drug resistant melanoma. It involves using liquid chromatography-multiple reaction monitoring mass spectrometry to measure biomarkers or molecules in blood and tissue that indicates cancer is present. These measurements can help researchers determine if a patient is responding to treatment.
The Associated Press looks at some anticipated changes to the "National Security Strategy, a document that previously outlined the Bush Doctrine of preventive war." The article focuses on the prospective strategy changes, but notes that the "revisions are part of a larger effort about which the White House talks openly, one that seeks to change not just how the U.S. talks to Muslim nations, but also what it talks to them about, from health care and science to business startups and education."
OrSense Ltd., developer of monitors for non-invasive measurements of various blood parameters, presented today at the AABB Annual Meeting & CTTXPO 2010, in Baltimore, Maryland, results showing that hemoglobin (Hb) measurements obtained by its NBM 200, a non-invasive Hb measurement system for anemia screening, showed accurate performance compared with invasive point of care (POC) devices.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Bolaji Olatoun Bolarinwa, 2 Buttonwood Ct, Moorestown, NJ 08057-1468 Ph: (856) 237-3597 | Bolaji Olatoun Bolarinwa, 750 Route 73 S Ste 105a, Marlton, NJ 08053-4142 Ph: (856) 282-5566 |
News Archive
Gen-Probe Incorporated announced today that the Company has begun a clinical trial intended to secure U.S. regulatory approval of its PROGENSA(R) PCA3 assay, a new molecular test that may help determine the need for a repeat prostate biopsy.
Moffitt Cancer Center researchers developed a new way to identify possible therapeutic targets for patients with drug resistant melanoma. It involves using liquid chromatography-multiple reaction monitoring mass spectrometry to measure biomarkers or molecules in blood and tissue that indicates cancer is present. These measurements can help researchers determine if a patient is responding to treatment.
The Associated Press looks at some anticipated changes to the "National Security Strategy, a document that previously outlined the Bush Doctrine of preventive war." The article focuses on the prospective strategy changes, but notes that the "revisions are part of a larger effort about which the White House talks openly, one that seeks to change not just how the U.S. talks to Muslim nations, but also what it talks to them about, from health care and science to business startups and education."
OrSense Ltd., developer of monitors for non-invasive measurements of various blood parameters, presented today at the AABB Annual Meeting & CTTXPO 2010, in Baltimore, Maryland, results showing that hemoglobin (Hb) measurements obtained by its NBM 200, a non-invasive Hb measurement system for anemia screening, showed accurate performance compared with invasive point of care (POC) devices.
› Verified 4 days ago
Jacquelyn Regina Zagone, PMHNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 777 Route 70 E Ste G101, Marlton, NJ 08053 Phone: 800-413-8020 | |
Dorothy Westlake, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1001 Rt. 73 North, Upper Level A & Main Level, Marlton, NJ 08053 Phone: 856-988-3444 | |
Phenita Sammantha Mouzon, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 777 Route 70 E Ste G101, Marlton, NJ 08053 Phone: 856-818-4020 | |
Mrs. Lisa Spurlock Abrams, APN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 765 E Route 70, Building A, Marlton, NJ 08053 Phone: 856-797-4721 | |
Rafia Nicola Grooms, DNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 765 Route 70 E Bldg A100, Marlton, NJ 08053 Phone: 856-797-4721 Fax: 856-797-4785 | |
Mrs. Yingqiao Chen, PMHNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2003 Lincoln Dr W Ste B, Marlton, NJ 08053 Phone: 856-886-8839 Fax: 856-210-1874 | |
Ms. Fleurdeliz Alabanzas Germodo, N.P. Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 141 Route 70 E Ste B, Marlton, NJ 08053 Phone: 856-596-9057 |